N
BIVI icon

Nuveen’s BioVie BIVI Stock Holding History

Nuveen’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-807
Closed -$102K – 3280
2023
Q4 		$102K Buy
807
+81
+11% +$24.3K ﹤0.01% 3285
2023
Q3 		$248K Hold
726
– – ﹤0.01% 2998
2023
Q2 		$313K Buy
+726
New +$489K ﹤0.01% 3011

Other funds holding BIVI

ACM
Altium Capital Management New York $42M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Nuveen's BIVI Position: Q1 2024 in Review

Nuveen sold out of BioVie (BIVI) in Q1 2024, closing a stake of 807 shares — an estimated $102K sold.

Nuveen first reported a position in BIVI in Q2 2023 and held it in 3 quarters. The position peaked at $313K in Q2 2023. 49 funds tracked by Wall St. Rank hold BIVI as of Q1 2024.

  • Nuveen reported no remaining BioVie position as of Q1 2024 after selling out during the quarter.
  • Nuveen sold 807 BioVie shares in Q1 2024, an estimated $102K.
  • Nuveen first reported a position in BioVie in Q2 2023 and held it in 3 quarters.
  • Nuveen's BioVie position peaked at $313K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held BioVie as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.